Hydrocortisone Butyrate Lotion Recalled Due to cGMP Deviations
Teligent Pharma is recalling Hydrocortisone Butyrate Lotion 0.1% nationwide due to cGMP deviations. The firm discontinued its stability study program, prompting recall of all products within expiry.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a cGMP deviation (discontinuation of stability studies). No illnesses, injuries, or safety incidents are reported in the source text. The hazard is procedural/compliance-based rather than involving reported harm or high-risk contamination.
Plain-English summary
Teligent Pharma, Inc. is recalling Hydrocortisone Butyrate Lotion, 0.1%, distributed nationwide in the USA and Puerto Rico. The affected product is supplied in 2 fl oz (59 mL) bottles (NDC 52565-087-02) and 4 fl oz (118 mL) bottles (NDC 52565-087-04). A total of 30,497 bottles are being recalled.
The recall was initiated because the firm is discontinuing its stability study program, which constitutes a deviation from current good manufacturing practices (cGMP). All products within expiry dates are included in this recall across all affected batch numbers.
Consumers who have this medication should consult their healthcare provider or pharmacist about what to do with their product and whether an alternative medication is needed. This is a prescription drug (Rx only); patients should not discontinue use without guidance from their healthcare provider.
The recalled product
- Product
- Hydrocortisone Butyrate Lotion, 0.1%, packaged in a) 2 fl oz (59 mL) bottles, NDC 52565-087-02; b) 4 fl oz (118 mL) bottles, NDC 52565-087-04, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Corticosteroid
- Affected units
- 30,497
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Batch: a) 16293
- Exp. 1/31/2023
- 16436
- 16451
- Exp. 2/28/2023
- b) 15105
- Exp. 2/28/2022
- 15290
- 15291
- 15292
- Exp. 3/31/2022
- 16293
- 16472
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19